[1] GUO Ya-nan, MAO Jing-yao, YU Tao *,.Theoretical Consideration of Corona Virus Disease 2019(COVID-19) [J]. Journal of Shaanxi University of Traditional Chinese Medicine, 2020, (预出版): 32-35.
Copy

Theoretical Consideration of Corona Virus Disease 2019(COVID-19)

References:

[1] Li Q, Guan X, Wu P, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia[J]. N. Engl. J. Med. 2020,1.29. doi: 10.1056/NEJMoa2001316. [Epub ahead of print]
[2] Nature.Coronavirus latest: WHO officially names disease COVID-19[EB/OL].[2020-2-11].https://www.nature.com/articles/d 41586-020-00154-w.
[3] 中华人民共和国国家卫生健康委员会卫生应急办公室.截至 2 月 21 日 24 时新型冠状病毒肺炎疫情最新情况 [EB/OL].(2020-02-22).http://www.nhc.gov.cn/xcs/yqfkdt/202002/543cc508978a48d2b9322bdc83daa6fd.shtml
[4] 国家卫生健康委员会.新型冠状病毒感染的肺炎诊疗方案(试行第六版)[EB/OL].[2020-02-18].
[5] 张明雪,曹洪欣,翁维良,等.从中医瘟疫理论识SARS主症特征[J].北京中医药大学学报,2006,29(3):196-199.
[6] 张贵生.SARS 流行病学特征再分析[J].疾病监测,2006,21(8):437-440.
[7] 田春敏,李培进,程刚,等.SARS 急性肺损伤及其激素治疗的探讨[J].解放军预防医学杂志,2007,25(5):387-389.
[8] Guan WJ, Ni ZY, Hu Y,et al. Clinical characteristics of 2019 novel coronavirus infection in China[J] . N Engl J Med,2020 ,2.28. doi: 10.1056/NEJMoa2002032. [Epub ahead of print]
[9] Shang L1, Zhao J2, Hu Y, et al. On the use of corticosteroids for 2019-nCoV pneumonia[J]. Lancet, 2020 ,395(10225):683-684. doi: 10.1016/S0140-6736(20)30361-5. Epub 2020 Feb 12.
[10] 王玉光,齐文升,马家驹,等.新型冠状病毒肺炎中医临床特征与辨证治疗初探[J].中医杂志,2020,61(4):281-285.
[11] 人参败毒散的各家各论[DB].(2014-11-20). https://wenku.baidu.com/view/9670384b192e45361066f5c4.html.
[12] 郑文科,张俊华,杨丰文,等.中医药防治新型冠状病毒感染的肺炎各地诊疗方案综合分析[J/OL].中医志:1-4[2020-02-22].http://kns--cnki--net--http.cnki.mm.qfclo.com:2222/kcms/detail/11.2166.r.20200206.1113.002.html.

Last Update: 2020-03-16
Copyright @ 2020 Journal of Shaanxi University of Chinese Medicine
 Address: Middle Section of Century Avenue, Xianyang, Shaanxi Province. Post Code: 712046
Tel: 029-38185250 Fax: 029-38185250 E-mail: shxzhzs@163.com Powered by: www.editorhome.cn